H.R. 7050 · 119th Congress · 2025–2026
Homeopathic Drug Product Safety, Quality, and Transparency Act
H.R. 7050 in the 119th Congress (2025–2026) was introduced on Jan 14, 2026, sponsored by Pete Sessions with 6 co-sponsors.
During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.
- Status
- Introduced
- Introduced
- Jan 14, 2026
- Co-sponsors
- 6
- Policy area
- Health
Sponsor
Pete Sessions (R-TX). Co-sponsors: 1 Democrat, 5 Republicans.
Where it stands
- IntroducedJan 14, 2026
- Passed the House—
- Passed the Senate—
- Sent to the President—
- Became law—
Latest action: Referred to the House Committee on Energy and Commerce. (Jan 14, 2026)
More bills from Pete Sessions in the 119th Congress
Other Health bills in the 119th Congress
- H.R. 766: SEWER Act
- H.R. 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025
- S. 2398: Kay Hagan Tick Reauthorization Act
- H.R. 12: Women’s Health Protection Act of 2025
- H.J.Res. 123: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the…
- S.J.Res. 197: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United…
- H.J.Res. 197: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the…
- H.R. 271: Defund Planned Parenthood Act of 2025
- H.R. 272: Protecting Life and Taxpayers Act of 2025
- H.R. 307: ARC Act of 2025
Committees
More
From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.
Cite or embed this page
Capitol Receipts, “H.R. 7050 (119th Congress): Homeopathic Drug Product Safety…,” https://www.capitolreceipts.com/bill/119-hr-7050/homeopathic-drug-product-safety-quality-and-transparency-act (accessed 2026-10-17).